New Narcolepsy Drug Restores Wakefulness for Patients
TL;DR Summary
A first-of-its-kind drug for type 1 narcolepsy reduces daytime sleepiness and cataplexy, giving patients longer wakeful periods and improved daily functioning, according to NEJM-backed coverage and patient accounts.
- A New Drug Lifts the Fog of Sleepiness for Those With Narcolepsy nytimes.com
- Takeda announces publication of data from Phase 3 studies of oveporexton TipRanks
- New Phase 3 Data on Oveporexton for Narcolepsy Type 1 Psychiatric Times
- Takeda’s oveporexton shows improvements in narcolepsy study By Investing.com Investing.com India
- New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life STT Info
Reading Insights
Total Reads
1
Unique Readers
5
Time Saved
16 min
vs 17 min read
Condensed
99%
3,273 → 28 words
Want the full story? Read the original article
Read on nytimes.com